MoonLake Immunotherapeutics (MLTX) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

MLTX is expected to report earnings to fall 12.45% to -49 cents per share on March 24

MoonLake Immunotherapeutics MLTX Stock Earnings Reports

Q4'24

Est.

$-0.49

Q3'24

Missed

by $0.12

Q2'24

Missed

by $0.11

Q1'24

Missed

by $0.02

Q4'23

Beat

by $0.11

The last earnings report on November 07 showed earnings per share of -56 cents, missing the estimate of -43 cents. With 106.56K shares outstanding, the current market capitalization sits at 3.31B.

View a ticker or compare two or three

Compare

MLTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For MLTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for MLTX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Dorfstrasse 29

Phone

+41 415108022

Employees

Web

https://www.moonlaketx.com